<DOC>
	<DOCNO>NCT03031327</DOCNO>
	<brief_summary>A 2 week randomize ( 1:1:1 ) , control , double-masked , parallel group , pre-market study . Patients ocular discomfort follow refractive surgery procedure ( within 6 month enrollment investigation ) evaluate baseline ( Day 1 ) , Week 2 ( day 15±2 day ) Week 3 follow-up visit ( day 22±2 , early exit ) .</brief_summary>
	<brief_title>A 2 Weeks Study Evaluate Tolerability , Safety , Permanence Ocular Surface Efficacy Two Concentrations Lubricin Eye Drops Versus Sodium Hyaluronate 0.18 % Eye Drops Patients With Ocular Discomfort Following Refractive Surgery</brief_title>
	<detailed_description>Thirty ( 30 ) patient ( 10 per arm ) randomize 1:1:1 Lubricin 20 µg/ml eye drop solution Lubricin 50 µg/ml eye drop solution sodium hyaluronate ( HA ) 0.18 % eye drop solution enrol . As primary objective study evaluate tolerability safety Lubricin ( 20 50 μg/mL ) eye drop solution administer 2 week patient ocular discomfort follow ocular refractive surgery , sample size calculate base clinical feasibility formal sample size calculation perform .</detailed_description>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>1 . Patients 18 year age old . 2 . Patients undergone ocular refractive surgery within 6 month Day 1 Visit . 3 . Patients ocular discomfort define SANDE score ≥ 30 baseline . 4 . Average VAS score ( dryness , foreign body sensation , burning/stinging , itching , pain , stick feeling , blur vision photophobia ) ≥ 25 mm ; 5 . Best correct distance visual acuity ( BCDVA ) score ≥ 0.1 decimal unit eye time study enrolment . 6 . Only patient satisfy Informed Consent requirement may include study . The patient and/or his/her legal representative must read , sign date Informed Consent document studyrelated procedure perform . The Informed Consent form sign patient and/or legal representative must approve Ethics Committee current study . 1 . Patients severe Dry Eye condition ( severity level 4 accord Report International Dry Eye Workshop DEWS , 2007 ) 2 . Best correct distance visual acuity ( BCDVA ) score &lt; 0.1 decimal unit either eye time study enrolment 3 . Evidence active ocular infection either eye 4 . History presence ocular surface disorder ocular discomfort either eye 5 . Use ocular topical medication study medication treatment ocular disease include artificial tear study period 6 . Use topical cyclosporine , topical corticosteroid topical medication treatment dry eye either eye within 30 day study enrolment 7 . History ocular surgery ( exclude laser refractive surgical procedure ) either eye within 30 day study enrolment . Ocular surgery allow study treatment period elective ocular surgery procedure plan duration followup period 8 . Known hypersensitivity one component study procedural medication 9 . Participation another clinical study time present study within 90 day screening/baseline visit 10 . History drug , medication alcohol abuse addiction . 11 . Females childbearing potential ( surgically sterilize postmenopausal least 1 year ) exclude participation study meet one follow condition : 1. currently pregnant , 2. positive result urine pregnancy test Screening/Baseline Visit , 3. intend become pregnant study treatment period , 4. breastfeeding , 5. willing use highly effective birth control measure , : Hormonal contraceptive oral , implanted , transdermal , injected and/or mechanical barrier method spermicide conjunction barrier condom diaphragm IUD ( intrauterine device ) entire course 30 day study treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Ocular Discomfort Following Refractive Surgery</keyword>
	<keyword>Refractive Surgery</keyword>
</DOC>